Revascularization Strategies in Women with Stable Cardiovascular Disease: What do the Trials Reveal?

Interv Cardiol Clin

Cardiovascular Medicine, Detroit Medical Center, DMC Cardiovascular Institute, Wayne State University School of Medicine, 3990 John R Suite# 8362, Detroit, MI 48201, USA. Electronic address:

Published: April 2012

Cardiovascular disease (CAD) is the leading cause of death worldwide in both women and men. Although the prevalence of CAD is less in women, those women affected by CAD die more often than men. Women are underrepresented in cardiovascular studies, making it difficult to determine the outcomes of different revascularization strategies. This review summarizes the current data on gender outcomes for percutaneous coronary intervention and coronary bypass grafting.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iccl.2012.02.005DOI Listing

Publication Analysis

Top Keywords

revascularization strategies
8
cardiovascular disease
8
women
5
strategies women
4
women stable
4
stable cardiovascular
4
disease trials
4
trials reveal?
4
reveal? cardiovascular
4
disease cad
4

Similar Publications

Background And Aims: In Bangladesh, data related to the future risk of dementia and its associated factors are scarce. Furthermore, no dementia risk prediction tool has yet been applied to estimate the risk in any population in Bangladesh. Therefore, our objective was to assess the risk of dementia and its associated factors among patients with coronary artery disease (CAD).

View Article and Find Full Text PDF

Background: Risk-benefit tradeoffs between restrictive versus liberal red blood cell transfusion strategies may vary across individuals. This exploratory analysis aimed to derive and evaluate individualized treatment effects of defined transfusion strategies in patients with acute MI and anemia with the goal of minimizing adverse cardiovascular outcomes.

Methods: This study analyzed 3,447 (98.

View Article and Find Full Text PDF

Objective: This study aims to evaluate the relationship between apolipoproteins (ApoA1, ApoB, and the ApoB/A1 ratio) and the incidence of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and impaired kidney function, assessing their potential role in secondary prevention.

Method: A prospective cohort of 1,640 patients with impaired kidney function who underwent percutaneous coronary intervention in China was analyzed. Patients were categorized based on the measurements of ApoA1, ApoB, and ApoB/A1 ratio.

View Article and Find Full Text PDF

Background: In patients with atherosclerotic occlusive diseases, systematic reviews and meta-analyses of randomized controlled trials (RCTs) report that antiplatelets, statins, and antihypertensives reduce the risk of major adverse cardiac events, need for revascularization procedures, mortality, and health care resource use. However, evidence suggests that these patients are not prescribed these medications adequately or do not adhere to them once prescribed.

Objective: We aim to systematically review and meta-analyze RCTs examining the effectiveness of implementation or adherence-supporting strategies for improving health care provider prescription of, or patient adherence to, guideline-recommended cardiovascular medications in patients with atherosclerotic occlusive disease.

View Article and Find Full Text PDF

Severe left main coronary artery (LMCA) lesions (≥50% stenosis) portend a poor prognosis and require urgent revascularization. In this study, we identified the incidence and clinical predictors of severe LMCA stenosis in patients with chronic coronary syndrome (CCS) who had undergone coronary angiography for the first time. Using a nationwide database registry, all the patients with CCS who had undergone coronary angiography were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!